# Phase 4 Heart Failure trials recruiting: 42 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 42 trials in phase 4 for Heart Failure that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Heart Failure trials: 42 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/heart-failure

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 42
- Recruiting or not yet: 42
- Read on: November 19, 2026

## Trials

The 25 newest of 42, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 24, 2026 | NCT07781462 | Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure | Alexandria University | Phase 4 | Not yet recruiting | Delirium in Intensive Care Unit, Acute Heart Failure (AHF) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781462) |
| August 14, 2026 | NCT07766109 | Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery | University Hospital, Toulouse | Phase 4 | Not yet recruiting | Heart Failure, Cardiac Surgery | 434 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766109) |
| July 13, 2026 | NCT07697833 | Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients | National Institute of Cardiovascular Diseases, Pakistan | Phase 4 | Not yet recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697833) |
| June 5, 2026 | NCT07631156 | STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure | Sponsor not shown (see the record) | Phase 4 | Recruiting | Heart Failure With Reduced Ejection Fraction, Heart Failure, Ventricular Dysfunction, Left | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07631156) |
| May 13, 2026 | NCT07583173 | Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | Heart Failure | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07583173) |
| May 7, 2026 | NCT07572032 | Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study | Sponsor not shown (see the record) | Phase 4 | Recruiting | Heart Failure Due to Coronary Artery Disease, Valvular Cardiomyopathy, Heart Failure | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572032) |
| April 28, 2026 | NCT07554638 | Incretin Therapies in Obesity-related HFpEF | Columbia University | Phase 4 | Recruiting | Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction, Obesity | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554638) |
| April 14, 2026 | NCT07527156 | Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure | Institute for Clinical and Experimental Medicine | Phase 4 | Recruiting | Acute Heart Failure (AHF), Cardiogenic Shock, Heart Failure, Ketones, Ketone Body Metabolism | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07527156) |
| April 13, 2026 | NCT07523867 | Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study | Hospital de Messejana Dr. Carlos Alberto Studart Gomes | Phase 4 | Not yet recruiting | Heart Failure, Diabetic Kidney Disease, Hyperkalemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07523867) |
| April 7, 2026 | NCT07513883 | The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission. | Ziekenhuis Oost-Limburg | Phase 4 | Recruiting | Heart Failure | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07513883) |
| March 19, 2026 | NCT07482943 | The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure | The University of Hong Kong | Phase 4 | Recruiting | Fontan, Heart Failure, Dapagliflozin, Cardiovascular Diseases, Sodium-GLucose coTransporter-2 Inhibitors | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07482943) |
| January 7, 2026 | NCT07322237 | DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | Recruiting | Cirrhotic Cardiomyopathy, Empagliflozin, Cardiometabolic Risk Factors, Cirrhosis | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322237) |
| January 7, 2026 | NCT07321509 | Digoxin After Acute Heart Failure (DIG-DICA) | Hospital General de Agudos "Dr. Cosme Argerich" | Phase 4 | Recruiting | Acute Heart Failure (AHF) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321509) |
| December 19, 2025 | NCT07295522 | Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? | IRCCS Policlinico S. Donato | Phase 4 | Recruiting | Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved... | 368 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07295522) |
| December 4, 2025 | NCT07263035 | Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure | Lakeland Regional Health Systems, Inc. | Phase 4 | Recruiting | Heart Failure, Heart Failure - NYHA II - IV, Heart Failure Acute, Acute Heart Failure (AHF) | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263035) |
| October 7, 2025 | NCT07210606 | Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment | VA Office of Research and Development | Phase 4 | Recruiting | Sleep Disordered Breathing, Able Bodied | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07210606) |
| September 17, 2025 | NCT07178145 | Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction | University of Virginia | Phase 4 | Recruiting | Heart Failure Preserved Ejection Fraction, Epicardial Adipose Tissue | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07178145) |
| August 1, 2025 | NCT07099859 | Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve... | Sponsor not shown (see the record) | Phase 4 | Recruiting | Heart Valve Diseases, Left Ventricle Remodeling, Aortic Regurgitation Disease, Heart Failure Congestive, Natriuretic... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07099859) |
| May 20, 2025 | NCT06979726 | Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure | University of Florida | Phase 4 | Recruiting | Heart Failure, Volume Overload | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06979726) |
| May 9, 2025 | NCT06964464 | Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator | University of Rochester | Phase 4 | Recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death, Ventricular Arrhythmia, Implantable... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06964464) |
| February 6, 2025 | NCT06812546 | Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Heart Failure, Acute Myocardial Infarction (AMI), Acute Heart Failure (AHF) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06812546) |
| January 27, 2025 | NCT06793670 | Landiolol in Mitral Valve Surgery | Università Vita-Salute San Raffaele | Phase 4 | Recruiting | Cardiac Failure, Low Cardiac Output Syndrome | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06793670) |
| November 26, 2024 | NCT06704633 | Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania | Sponsor not shown (see the record) | Phase 4 | Recruiting | Heart Failure | 298 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06704633) |
| November 4, 2024 | NCT06671990 | The CardioMEMS Vericiguat Heart Failure Trial | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Heart Failure, Pulmonary Arterial Hypertension | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06671990) |
| October 15, 2024 | NCT06642272 | A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record | Herlev and Gentofte Hospital | Phase 4 | Recruiting | Diabetes Mellitus, Type 2, Heart Failure, Chronic Kidney Diseases | 17,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06642272) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| China-Japan Friendship Hospital | 2 |
| University of Virginia | 2 |
| Columbia University | 1 |
| Hospital General de Agudos "Dr. Cosme Argerich" | 1 |
| Institute for Clinical and Experimental Medicine | 1 |
| National Institute of Cardiovascular Diseases, Pakistan | 1 |
| IRCCS Policlinico S. Donato | 1 |
| University of Rochester | 1 |
| Samsung Medical Center | 1 |
| Ziekenhuis Oost-Limburg | 1 |
| The Cleveland Clinic | 1 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
| Università Vita-Salute San Raffaele | 1 |
| University of Florida | 1 |
| Charite University, Berlin, Germany | 1 |
| Weill Medical College of Cornell University | 1 |
| Herlev and Gentofte Hospital | 1 |
| Cairo University | 1 |
| Alexandria University | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Heart Center Research, LLC | 1 |
| The University of Hong Kong | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| University Hospital, Toulouse | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 11 |
| China | 5 |
| South Korea | 4 |
| Italy | 3 |
| Denmark | 2 |
| Poland | 2 |
| Spain | 2 |
| Argentina | 1 |
| Czechia | 1 |
| Belgium | 1 |
| Brazil | 1 |
| Germany | 1 |
| Egypt | 1 |
| India | 1 |
| Hong Kong | 1 |
| France | 1 |
| Taiwan | 1 |
| Australia | 1 |
| Canada | 1 |
| United Kingdom | 1 |
| Tanzania | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Flour mills in the United States](https://specstream.ai/data/businesses/flour-mills/united-states)
- [Marketing agencies in the United States](https://specstream.ai/data/businesses/marketing-agencies/united-states)
- [Real estate firms in the United States](https://specstream.ai/data/businesses/real-estate-firms/united-states)
- [Waterproofing contractors in the United States](https://specstream.ai/data/businesses/waterproofing-contractors/united-states)
- [Business financing companies in the United States](https://specstream.ai/data/businesses/business-financing-companies/united-states)
- [Fabric wholesalers in the United States](https://specstream.ai/data/businesses/fabric-wholesalers/united-states)
